09:59 AM EST - ADVANZ PHARMA Corp. Limited : Announced its financial and operational results for the three and 12 months ended December 31, 2020. All financial references are in U.S. dollars unless otherwise noted. 2020 revenue was $526 million and fourth quarter 2020 revenue was $135 million. 2020 net loss of $75 million and fourth-quarter net income of $2.4 million. 2020 Adjusted EBITDA was $233 million and fourth-quarter 2020 Adjusted EBITDA of $51 million. Generated cash flow from operations of $166 million in 2020 and concluded the year with a cash and cash equivalents balance of $160 million. ADVANZ PHARMA Corp. Limited
shares T.ADVZ are trading unchanged at $6.20.
